D.E. Shaw & Co’s Cyclerion Therapeutics CYCN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-6,112
| Closed | -$136K | – | 4202 |
|
|
2022
Q1 | $136K | Sell |
6,112
-718
| -11% | -$16K | ﹤0.01% | 3707 |
|
|
2021
Q4 | $235K | Sell |
6,830
-6,798
| -50% | -$234K | ﹤0.01% | 3418 |
|
|
2021
Q3 | $837K | Sell |
13,628
-5,135
| -27% | -$315K | ﹤0.01% | 2587 |
|
|
2021
Q2 | $1.46M | Buy |
18,763
+15,339
| +448% | +$1.2M | ﹤0.01% | 2286 |
|
|
2021
Q1 | $191K | Sell |
3,424
-5,640
| -62% | -$315K | ﹤0.01% | 2799 |
|
|
2020
Q4 | $555K | Buy |
9,064
+4,187
| +86% | +$256K | ﹤0.01% | 2248 |
|
|
2020
Q3 | $593K | Sell |
4,877
-2,246
| -32% | -$273K | ﹤0.01% | 2057 |
|
|
2020
Q2 | $842K | Buy |
7,123
+2,768
| +64% | +$327K | ﹤0.01% | 1971 |
|
|
2020
Q1 | $231K | Sell |
4,355
-9,284
| -68% | -$492K | ﹤0.01% | 2410 |
|
|
2019
Q4 | $742K | Buy |
13,639
+8,142
| +148% | +$443K | ﹤0.01% | 2045 |
|
|
2019
Q3 | $1.33M | Buy |
5,497
+15
| +0.3% | +$3.64K | ﹤0.01% | 1745 |
|
|
2019
Q2 | $1.26M | Buy |
+5,482
| New | +$1.26M | ﹤0.01% | 1798 |
|